Wednesday, Aug 05, 2020 | Last Update : 04:05 AM IST

133rd Day Of Lockdown

Maharashtra45795629935616142 Tamil Nadu2682852087844349 Andhra Pradesh176333956251604 Karnataka145830692722704 Delhi1391561252264033 Uttar Pradesh100310572711817 West Bengal80984568841785 Telangana6894649675563 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  World   South Asia  20 Jul 2020  Bangladesh allows late-stage trial of China's Sinovac COVID-19 vaccine

Bangladesh allows late-stage trial of China's Sinovac COVID-19 vaccine

REUTERS
Published : Jul 20, 2020, 5:57 pm IST
Updated : Jul 20, 2020, 5:57 pm IST

Sinovac has been looking for volunteers outside of China as the number of coronavirus cases there has dwindled

A lab technician wearing Personal Protective Equipment (PPE) takes reagent bottles to perform vaccine tests. (AFP)
 A lab technician wearing Personal Protective Equipment (PPE) takes reagent bottles to perform vaccine tests. (AFP)

Dhaka: Bangladesh has approved the third-phase trial of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd, officials said on Monday, as infections continue to rise in the densely-populated South Asian country.

Sinovac has been looking for volunteers outside of China as the number of coronavirus cases there has dwindled, said a member of Bangladesh’s national technical advisory committee to tackle COVID-19.

 

The International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), will conduct the trial that could begin next month.

“We have given ethical permission for the trial after reviewing the research protocol,” Mahmood Uz Jahan, director of the Bangladesh Medical Research Council (BMRC), told Reuters.

“The protocol given to BMRC by ICDDR,B will be applied to 4,200 volunteers. Half of them will get vaccinated.”

The trial would be conducted in seven COVID-19 hospitals in Dhaka, Bangladesh’s capital, an ICDDR,B official said on the condition of anonymity.

The country had 204,525 confirmed coronavirus cases as of Sunday, with 2,618 deaths.

 

Sinovac said this month it was starting Phase III trials of its potential coronavirus vaccine in Brazil.

A senior Bangladesh health ministry official said the country hoped to get priority in securing the vaccine should it prove effective in the trials.

Tags: bangladesh, china coronavirus vaccine, covid-19 vaccine, china vaccine, sinovac biotech, human trial